A panel of monoclonal antibodies recognizing the Staphylococcus epidermidis fibrinogen-binding MSCRAMM SdrG

Andrea E Hall1, Pratiksha R Patel, Paul J Domanski

  • 1Inhibitex, Inc., Alpharetta, Georgia 30004, USA.

Hybridoma (2005)
|February 24, 2007
PubMed

Insights

Researchers developed monoclonal antibodies (MAbs) targeting SdrG, a key adhesin in Staphylococcus epidermidis foreign-body infections. These MAbs aid in understanding SdrG's role in bacterial adherence and developing new treatments.

Area of Science:

  • Microbiology
  • Immunology
  • Infectious Diseases

Background:

  • Staphylococcus epidermidis is a significant opportunistic pathogen causing foreign-body infections.
  • Bacterial adherence to host tissues is crucial for S. epidermidis pathogenesis.
  • SdrG, a fibrinogen-binding adhesin, mediates bacterial attachment to foreign materials like catheters.

Purpose of the Study:

  • To generate and characterize monoclonal antibodies (MAbs) against the S. epidermidis virulence factor SdrG.
  • To investigate the potential of these MAbs in studying the biological role of SdrG.

Main Methods:

  • Generation of a panel of monoclonal antibodies (MAbs).
  • Characterization using in vitro assays, surface plasmon resonance (SPR), and flow cytometry.

Main Results:

  • A diverse set of MAbs targeting SdrG was successfully generated and characterized.
  • The MAbs demonstrated varied binding properties and specificities.

Conclusions:

  • The developed MAbs provide valuable tools for further research into SdrG's function.
  • These MAbs may contribute to understanding and combating S. epidermidis foreign-body infections.

Related Concept Videos